ArticleMolecular and clinical oncology2017

Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer.

Ki Sun Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.